Microgreenskit – The World Health Organization (WHO) announced this week that hydroxychloroquine could not be used to prevent or treat COVID-19. Former President Donald Trump once advertised the anti-inflammatory drug, claiming he was using it to stop contracting coronavirus last spring.
According to a group of WHO experts, the medication has no discernible effect on coronavirus-related deaths or hospitalizations. They went on to suggest that it might also raise the likelihood of side effects.
“The guideline creation panel made a clear recommendation against the use of hydroxychloroquine for individuals who do not have covid-19,” the panel wrote in The BMJ on Tuesday, citing high certainty.
“Almost no one will consider this medication worthwhile, according to the panel.”
Six randomized clinical trials involving over 6,000 participants — both with and without documented exposure to the virus — provided the evidence.
The panel concluded that hydroxychloroquine is no longer a high priority for science and that scientists should now concentrate their energies on other promising preventive drugs. According to the report, more than 80 trials with cumulative participation of at least 100,000 people expected to study hydroxychloroquine further should be canceled.
The medication used to treat malaria, lupus, and rheumatoid arthritis, rose to prominence after being heavily marketed by Mr. Trump and other members of his administration. In October, the former president became infected with the virus and sought care at Walter Reed Medical Center with an illegal monoclonal antibody.
Last March, the FDA released an emergency use permit for the drug. After finding that the medication is “unlikely to be successful in treating COVID-19 for the approved uses,” it revoked the June license.
Because of the risk of side effects, especially heart rhythm issues, federal regulators had previously recommended against using hydroxychloroquine outside of hospitals and formal studies.